ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, cilt.12, sa.6, ss.680-684, 2021 (ESCI)
Aim: Although limited risk factors were observed with the accumulated evidence during the SARS-CoV-2 (COVID-19) pandemic, there is still a lack of evidence for markers distinguishing asymptomatic-mild disease from severe disease. In this study, we aimed to evaluate the prognostic impact of sarcopenia and visceral adipose tissue in ICU patients treated for COVID-19.